Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ten-Year Clinical Outcomes of Endoscope-Assisted Minimally Invasive Surgical Decompression for Lumbar Spinal Stenosis with Degenerative Spondylolisthesis and Comparison with Conservative Treatment.
Nambu K, Numata H, Yoshitani J, Suzuki K, Takemoto N, Kimura H, Komine N, Goshima K, Mikami Y, Hatsuchi Y, Ishikawa T, Higuchi T, Oku N, Asai K, Morinaga S. Nambu K, et al. Among authors: kimura h. Spine Surg Relat Res. 2023 Oct 13;8(1):73-82. doi: 10.22603/ssrr.2023-0093. eCollection 2024 Jan 27. Spine Surg Relat Res. 2023. PMID: 38343406 Free PMC article.
DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts.
Morinaga S, Han Q, Kubota Y, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: kimura h. Anticancer Res. 2024 Jun;44(6):2359-2367. doi: 10.21873/anticanres.17043. Anticancer Res. 2024. PMID: 38821601
Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma.
Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: kimura h. Anticancer Res. 2024 Aug;44(8):3261-3268. doi: 10.21873/anticanres.17144. Anticancer Res. 2024. PMID: 39060039
Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem.
Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: kimura h. Anticancer Res. 2024 Sep;44(9):3785-3791. doi: 10.21873/anticanres.17203. Anticancer Res. 2024. PMID: 39197928
Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma.
Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: kimura h. Anticancer Res. 2024 Sep;44(9):3777-3783. doi: 10.21873/anticanres.17202. Anticancer Res. 2024. PMID: 39197933
The Role of Microsurgery and Fluorescent-reporter Genes in Establishing Mouse Models for Real-Time Imaging of Metastatic Cancer-Cell Trafficking and Colony Formation: A Revolutionary and Disruptive Technology for Metastasis Research.
Morinaga S, Yamamoto N, Yamauchi K, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: kimura h. Cancer Diagn Progn. 2024 Sep 1;4(5):544-557. doi: 10.21873/cdp.10362. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238629 Free PMC article. Review.
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time.
Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: kimura h. Cancer Genomics Proteomics. 2024 Nov-Dec;21(6):585-590. doi: 10.21873/cgp.20475. Cancer Genomics Proteomics. 2024. PMID: 39467627 Free PMC article.
5,927 results